(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|
Turnover | -82.43%31.05M | 35.99%440.55M | --176.74M | 70.91%323.96M | 48.76%189.55M | 57.54%127.43M | --80.89M |
Operating income | -82.43%31.05M | 35.99%440.55M | 176.74M | 70.91%323.96M | 48.76%189.55M | 57.54%127.43M | 80.89M |
Cost of sales | 80.12%-29.73M | -56.17%-356.72M | ---149.54M | -106.24%-228.41M | -45.64%-110.75M | -70.94%-76.04M | ---44.49M |
Operating expenses | 80.12%-29.73M | -56.17%-356.72M | -149.54M | -106.24%-228.41M | -45.64%-110.75M | -70.94%-76.04M | -44.49M |
Gross profit | -95.13%1.33M | -12.27%83.83M | 27.2M | 21.26%95.55M | 53.36%78.8M | 41.16%51.38M | 36.4M |
Selling expenses | 27.34%-978K | 4.69%-3.58M | ---1.35M | -75.37%-3.75M | -26.78%-2.14M | 31.77%-1.69M | ---2.47M |
Administrative expenses | -86.86%-25.99M | 20.57%-38.11M | ---13.91M | -69.80%-47.98M | -86.81%-28.26M | -7.96%-15.13M | ---14.01M |
Impairment and provision | -271.19%-6.48M | 17.87%-10M | ---1.75M | -6.12%-12.18M | -137.98%-11.48M | -59.75%-4.82M | ---3.02M |
-Other impairment is provision | -271.19%-6.48M | 17.87%-10M | ---1.75M | -6.12%-12.18M | -137.98%-11.48M | -59.75%-4.82M | ---3.02M |
Special items of operating profit | -23.78%1.5M | 39.77%2.54M | --1.97M | -50.12%1.82M | 6.70%3.65M | -0.41%3.42M | --3.43M |
Operating profit | -351.53%-30.62M | 3.66%34.68M | 12.17M | -17.54%33.45M | 22.34%40.57M | 63.16%33.16M | 20.32M |
Financing cost | 3.20%-121K | -0.46%-220K | ---125K | 56.20%-219K | -36.61%-500K | 78.32%-366K | ---1.69M |
Earning before tax | -355.14%-30.74M | 3.68%34.46M | 12.05M | -17.06%33.23M | 22.18%40.07M | 75.98%32.79M | 18.64M |
Tax | ---- | -89.49%-8.96M | ---1.76M | 16.84%-4.73M | -34.15%-5.69M | -230.22%-4.24M | ---1.28M |
After-tax profit from continuing operations | -398.73%-30.74M | -10.56%25.49M | 10.29M | -17.09%28.5M | 20.41%34.38M | 64.56%28.55M | 17.35M |
Earning after tax | -398.73%-30.74M | -10.56%25.49M | 10.29M | -17.09%28.5M | 20.41%34.38M | 64.56%28.55M | 17.35M |
Profit attributable to shareholders | -398.73%-30.74M | -10.56%25.49M | 10.29M | -17.09%28.5M | 20.41%34.38M | 64.56%28.55M | 17.35M |
Basic earnings per share | -413.10%-0.1434 | -22.24%0.1161 | 0.0458 | -17.92%0.1493 | -99.55%0.1819 | 100.00%40 | 20 |
Diluted earnings per share | -415.16%-0.1434 | -22.64%0.1155 | 0.0455 | -17.92%0.1493 | -99.55%0.1819 | 100.00%40 | 20 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data